Synthroid is usually used as a replacement for a hormone normally produced by your thyroid gland. The hormone is necessary to regulate the body’s energy and metabolism.
Arimidex is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer. Your doctor may prescribe this remedy for other purposes. Contact your physician to learn more information.
Droxia is known as an anti-cancer. It slows the growth of cancer cells.
Generally, Rheumatrex is an antimetabolite that acts by blocking an enzyme needed for cell growth and by suppressing the immune system. By blocking the enzyme, it slows the growth of certain cells of the body, especially cells that reproduce quickly, such as bone marrow cells, skin cells and cancer cells.
Vepesid, VP-16 is a chemotherapy drug. This remedy slows the growth of cancer sells and spread in the body.
Cytoxan is known as an anti-cancer chemotherapy remedy. It is prescribed to treat several types of cancer. It slows the growth of cancer cells.
Kytril is a serotonin 5-HT3 receptor antagonist used as an antiemetic. Kytril is prescribed to prevent nausea and vomiting due to cancer treatment (chemotherapy) and radiation therapy.
Femara (letrozole) is prescribed for the adjuvant (following surgery) treatment of postmenopausal women with hormone receptor-positive early stage breast cancer. You may see the positive result within 24 months of treatment. It is prescribed for treatment of early stage and advanced breast cancer in postmenopausal females and in women with estrogen receptor-positive or estrogen receptor-unknown breast cancer that has spread to another part of the body (metastatic cancer).
Premarin contains a combination of estrogen hormones which treat symptoms of menopause, such as vaginal dryness, hot flashes, irritation and burning. It can be prescribed also to prevent osteoporosis (loss of bone mass) in postmenopausal females, and to replace estrogen in females with ovarian failure or other conditions that cause a lack of natural estrogen.
Evista is usually prescribed to prevent and treat osteoporosis in postmenopausal females; to reduse risk of invasive breast cancer in postmenopausal females with osteoporosis and with the risk for invasive breast cancer. Your doctor may recommend Evista if you already have or have had breast cancer.